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osting by EAbstract The aim of the study was to investigate the therapeutic effect of aqueous extracts of some
traditional medicinal plants (including Camellia sinensis leaves, Carum carvi seeds, Alpinia galangal
rhizomes, Boswellia serrata resins and Cenchona ofﬁcinalis bark) compared to the anticancer drug,
methotrexate (MTX) against aﬂatoxicosis induced by aﬂatoxin-B1 (AFB1) in both kidneys and
hearts of rats. Administration of AFB1 induces oxidative stress in kidneys of AFB1-treated rats
through elevating the level of malondialdehyde (MDA) and depleting the levels of tissue antioxi-
dants, glutathione reductase (GR), glucose-6-phosphate dehydrogenase (G-6-PDH) and vitamin
C. Also the result revealed that aﬂatoxicosis interfere with the cellular energy supply of rat hearts
through its inhibitory action on some markers of energy metabolism indicated by a decrease in glu-
cose and glycogen contents of heart and a reduction in the activities of some glycolytic enzymes,
phosphogluco-isomerase (PGI), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and lactate
dehydrogenase (LDH) compared to normal healthy animals.
Supplementation of the aqueous extracts of the different plant used, effectively ameliorated the
deviation induced in both kidneys and hearts of animals in response to AFB1 administration. This
effect was evident through reducing MDA level and up-regulating the inhibitory effect of AFB1 on
the levels of antioxidants in kidneys as well as the energetic biomarkers in hearts. However, admin-
istration of MTX to AFB1-treated rats dramatically ampliﬁed the toxic effect of aﬂatoxicosis, indi-
cated by marked increment in MDA level and decrease in the levels of antioxidants in kidneys of
AFB1-MTX group in relation to AFB1 group. Also the same response was found in the bioener-
getic markers of hearts. From the current investigation, it can be suggested that supplementation of.com
ity. All rights reserved. Peer-
d University.
lsevier
2 N. Ameen Abdulmajeedthe extracts of the different plants presented in this study was beneﬁcial in modulating the altera-
tions induced in kidney and heart under the toxic effects of AFB1.
ª 2010 King Saud University. All rights reserved.1. Introduction
Aﬂatoxins are secondary toxic fungal metabolites produced by
Aspergillus ﬂavus and A. parasiticus. There are four naturally
occurring aﬂatoxins, the most toxic being aﬂatoxin B1
(AFB1), and three structurally similar compounds namely aﬂa-
toxin B2 (AFB2), aﬂatoxin G1 (AFG1) and aﬂatoxin G2
(AFG2). Aﬂatoxins not only contaminate our food stuffs but
are also found in edible tissues, milk and eggs after consump-
tion of contaminated feed by farm animals (Bennett and Klich,
2003; Fink-Gremmels, 1999).
Aﬂatoxins are well known to be potent mutagens, carcino-
genic, teratogenic, immunosuppressive and also inhibit several
metabolic systems, causing liver, kidney and heart damage.
These toxins have been incriminated as the cause of high mor-
tality in livestock and some cases of death in human being
(Minto and Townsend, 1997; Wogan, 1999; Bintvihok, 2002;
Wangikar et al., 2005; Salunkhe et al., 1987).
The mechanism of AFB1 toxic effect has been extensively
studied. It has been shown that AFB1 is activated by hepatic
cytochrome P450 enzyme system to produce a highly reactive
intermediate, AFB1-8,9-epoxide, which subsequently binds to
nucleophilic sites in DNA, and the major adduct 8,9-dihydro-
8-(N7guanyl)-9-hydroxy-AFB1 (AFB1 N7-Gua) is formed.
The formation of AFB1-DNA adducts is regarded as a critical
step in the initiation of AFB1-induced carcinogenesis (Sharma
and Farmer, 2004; Klein, 2002; Preston and Williams, 2005).
Although the mechanism underlying the toxicity of aﬂatox-
ins is not fully understood, several reports suggest that toxicity
may ensue through the generation of intracellular reactive oxy-
gen species (ROS) like superoxide anion, hydroxyl radical and
hydrogen peroxide (H2O2) during the metabolic processing of
AFB1 by cytochrome P450 in the liver. These species may at-
tack soluble cell compounds as well as membranes, eventually
leading to the impairment of cell functioning and cytolysis
(Towner et al., 2003; Sohn et al., 2003; Berg et al., 2004).
Natural substances that can prevent AFB1 toxicity would
be helpful to human and animal health with minimal cost in
foods and feed. Traditional medicinal plants were used by
some authors for their antifungal, anti-aﬂatoxigenic and anti-
oxidant activity (Joseph et al., 2005; Kumar et al., 2007).
Green tea (Camellia sinensis, family Theaceae) has been
found to possess many health beneﬁts including protection
of oxidative DNA damage, lowering atherosclerotic index,
and improving blood ﬂow, liver function and oral health. It
also has antimicrobial and antioxidant activities (Dufresne
and Farnworth, 2001; McKay and Blumberg, 2002; Almajano
et al., 2008; Panza et al., 2008).
The functional properties of tea are due to its polyphenols.
Tea catechins are the principal tea polyphenols, which are
mainly present in green tea and exhibit the most effective anti-
oxidant activity compared to other tea polyphenols. Among
tea catechins, epigallocatechin gallate (EGCG) is the most
abundant and efﬁcient catechin (Almajano et al., 2008; Panza
et al., 2008).Caraway (Carum carvi L., family, Umbelliferae) is another
traditional medicinal plant. The aqueous extract of caraway is
used as an aperitif, tranquilizer, carminative, diuretic. The
seeds are used to treat ailments such as ﬂatulence, colic pain
and bronchitis (Bellakhdar et al., 1997; Lahlou et al., 2007;
de Carvalho and da Fonseca, 2006).
Galangal (Alpinia galangal, family, Zingiberaceae) has tra-
ditionally been used as spice foods. This spice is, like other
spices, rich in phenolic compounds such as ﬂavonoids and phe-
nolic acids which contribute to the overall its antioxidant
activities (Juntachote and Berghofer, 2005). Galangal is used
for medical purposes such as carminative, stomachic (Yang
and Eilerman, 1999) antispasmodic, antiphlogistic and antimi-
crobial (Viljoen et al., 2003; Oonmetta-aree et al., 2006).
Frankincense (Boswellia serrata, family, Frankincense) is a
gum resin secreted by trees of the genus Boswellia of Bursera-
ceae. It has been used for therapeutic purposes as a remedy,
especially in the traditional Ayurvedic medicine of India. It
was reported that frankincense exerted anti-inﬂammatory,
antidiabetic, antiarthritic, anticancer and immunomodulatory
activities in animals (Al-Wadi and Gumaa, 1987; Reddy
et al., 1986; Hostanska et al., 2002; Miklaeil et al., 2003).
The active principles, boswellic acids, prevent endotoxin-/
galactosamine-induced hepatitis in mice (Safayhi et al., 1991).
It also exhibits marked sedative and analgesic effects (Knaus
and Wagner, 1996). Boswellia has also been observed to inhibit
human leukocyte elastase (HLE), which may be involved in the
pathogenesis of emphysema. It also stimulates mucus secretion
and thus may play a role in cystic ﬁbrosis, chronic bronchitis
and acute respiratory distress syndrome (Safayhi et al., 1991,
1997; Knaus and Wagner, 1996; Rall et al., 1996).
Cinchona (Cenchona ofﬁcinalis, family, Rubiaceae) is an-
other medicinal plant used for treatment of some diseases. It
exhibits antimicrobial activity against bacteria and fungi.
The bark of cinchona contains the alkaloid quinine along with
several other alkaloids effective against malaria and other par-
asitic infection, quinovic acid is effective as antitumor and
quinidine is used in the treatment of heart diseases (Rojas
et al., 2006; Mturi et al., 2002; Trepardoux, 2002; Raffauf
et al., 1978; Prinz, 1990).
Methotrexate (MTX) is widely used as a cytotoxic chemo-
therapeutic agent to treat various neoplastic diseases such as
acute lymphoblastic leukemia, lymphoma, solid cancers and
autoimmune diseases such as psoriasis and rheumatoid arthri-
tis (Antunes et al., 2002; Brock and Jenning, 2004; Doan and
Massarotti, 2005). However, the efﬁcacy of this agent often
is limited by severe side effects and toxic sequelae. Since the
cytotoxic effect of MTX is not selective for the cancer cells,
it also affects the normal tissues.
MTX administration has been reported to cause acute re-
nal failure, hepatotoxicity characterised by necrosis and ﬁbro-
sis, neurotoxicity and intestinal mucosa oxidative stress
(Walker et al., 2000; Sener et al., 2006; Jahovic et al., 2003;
Vezmar et al., 2003; Uzar et al., 2006; Miyazono et al.,
2004; Cetiner et al., 2005).
Therapeutic ability of some plant extracts on aﬂatoxin B1 induced renal and cardiac damage 3Relatively little is known about metabolic alterations occur-
ring in kidney and heart during aﬂatoxicosis. So the objective of
this study is to evaluate the metabolic disorders induced pathol-
ogy in kidneys and hearts of rats by the exposure toAFB1. Also,
the therapeutic beneﬁts of some medicinal plant aqueous ex-
tracts in comparison to the currently available anticancer drug,
MTX, against these disorders were also investigated.
This can be achieved through measuring some markers of
oxidative tissue damage in kidney such as thiobarbituric acid
reactive substances (TBARS, index of lipid peroxidation), the
antioxidant markers, glutathione reductase (GR), glucose-6-
phosphate dehydrogenase (G-6-PDH), vitamin C and some
indices of energy metabolism in heart [as glycogen, glucose
and the glycolytic enzymes, phosphogluco-isomerase (PGI),
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and lac-
tate dehydrogenase (LDH)].
2. Materials and methods
2.1. Chemicals
All chemicals used were of high analytical grade, product of Sigma
(US), Merk (Germany) and BDH (England). AFB1 was obtained
from Sigma chemical company (St. Louis, Missouri, USA).
2.2. Preparation of plant extracts
Twenty grams of dried plants were slowly boiled in 200 ml of
distilled water and heated for 30 min. The extracts were then
centrifuged, ﬁltered, frozen at 20 C and then lyophilized.
The obtained dry extract was dissolved in water and used di-
rectly for the treatment of animals using a particular dose
according to (Paget and Barnes, 1964).
2.3. Animals
Eighty male albino rats of Sprague–Dawley strain weighing
100–120 g were used for this study. Animals were housed in
clean metabolic cages and maintained under standard condi-
tions (23 ± 2 C and 12 h light/dark cycles). They were given
standard pellet diet and water ad libitum and kept for two
weeks to acclimatize to the environmental conditions.
2.3.1. Experimental design
The animals were divided into 8 groups:
 Group1: normal control rats.
 Group2: aﬂatoxin-treated group (1 mg/kg body weight of
rats).
 Group 3: aﬂatoxin-green tea leaves (Camellia sinensis) trea-
ted group (200 mg/kg body weight of rats).
 Group 4: aﬂatoxin-caraway seeds (Carum carvi) treated
group (2 mg/kg body weight of rats).
 Group 5: aﬂatoxin-galangal rhizomes (Alpinia galanga)
treated group (1 mg/kg body weight of rats).
 Group 6: aﬂatoxin-cinchona bark (Cinchona ofﬁcinalis)
treated group (1 g/kg body weight of rats).
 Group 7: aﬂatoxin-frankincense resins (Boswellia serrata)
treated group (1.25 g/kg body weight of rats).
 Group 8: aﬂatoxin-methotrexate treated group (0.5 mg/kg
body weight of rats).Aﬂatoxin B1 was administered intraperitoneally at a sin-
gle dose (1 mg/kg) to the rats of different experimental
groups except normal control group which injected intraper-
itoneally with normal saline, 0.9% NaCl. The extracts of
different plants were administered orally one week after
AFB1 injection daily for three weeks. Methotrexate was
administered intramuscular after one week of aﬂatoxin injec-
tion and this was repeated 24 h later (Preetha et al., 2006;
Rofe et al., 1994).
At the end of the experiment (4 weeks), animals in all
groups were sacriﬁced. The kidney and the heart from different
animal groups were immediately removed, weighed and
homogenized in ice cold bi-distilled water to yield 10% homog-
enates using a glass homogenizer. The homogenates were cen-
trifuged for 15 min at 10,000 rpm at 4 C and the supernatants
were used for different biochemical analysis except glycogen
which was extracted by using 30% potassium hydroxide for
its biochemical determination.2.4. Biochemical analysis
All the following parameters were measured spectrophoto-
metrically.
2.4.1. Lipid peroxidation
Lipid peroxidation was assayed by measuring the formed
malondialdehyde (MDA) (an end product of fatty acid per-
oxidation) by using thiobarbituric acid reactive substances
(TBARS) method. MDA concentration was calculated using
extinction coefﬁcient value (e) of 1.56 · 105/M/cm (Buege and
Aust, 1978). Results are expressed as lmol MDA formed/g
tissue.
2.4.2. Vitamin C
Vitamin C was estimated by the method of Jagota and Dani
(1982) using Folin–Ciocalteu reagent. The colour developed
was read at 760 nm. The vitamin C content is expressed as
lg/g tissue.
2.4.3. Glucose and glycogen estimations
Glucose level was estimated using Diamond Diagnostic Kits
(Trinder, 1962). Glycogen content was estimated by the meth-
od of Nicholas et al. (1956) using 30% KOH and anthrone
reagent.
2.4.4. Glucose-6-phosphate dehydrogenase assay (G-6-PDH)
The enzyme activitywas assayed in a reactionmixture contained
triethanolamine buffer (86 mM, pH 7.6), MgCl2 (6.9 mM),
glucose-6-phosphate (1 mM), NADP (0.39 mM). The reduction
of NADP was followed at 340 nm and one unit of activity is
deﬁned as the reduction of 1 nmol NADP+/min/mg protein
(Bergmeyer, 1974).
2.4.5. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
GAPDH activity in the oxidative phosphorylation was deter-
mined by monitoring NADH generation at 340 nm. The reac-
tion mixture of 1 ml contained 50 mM Tris buffer, pH 8.5,
10 mM sodium arsenate, 1 mM NAD+ and 2 mM D-G3P
(Serrano et al., 1991).
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4 N. Ameen Abdulmajeed2.4.6. Glucose isomerase (GI)
The enzyme activity was measured in a reaction medium con-
taining Tris-HCl buffer (0.2 M, pH 7.4), fructose-6-phosphate
(5 mM), MgCl2 (10 mM), NADP (0.2 mM). The increase in
extinction at 340 nm due to NADPH production was recorded
(Wu and Racker, 1959).
2.4.7. Lactate dehydrogenase assay (LDH)
The enzyme activity was evaluated in a reaction medium of
Tris buffer (50 Mm, pH 7.5), sodium pyruvate (0.6 mM),
NADH (0.18 mM). The rate of NADH consumption is deter-
mined at 340 nm and is directly proportional to the LDH
activity in the sample (Bergmeyer, 1975).
2.5. Statistical analysis
The results are expressed as mean ± standard deviation (SD).
Differences between groups were assessed by one-way analysis
of variance using the SPSS software package for Windows.
Post hoc testing was performed for inter-group comparisons
using the least signiﬁcance difference (LSD).
3. Results
Table 1 reveals the abnormal levels of kidney oxidative stress
biomarkers in rats that indicate the cellular damage caused
by AFB1 treatment. The level of MDA in kidney tissue was
markedly increased with concomitant signiﬁcant decrease in
the activities of tissue GR and G-6-PDH as well as in vitamin
C level in AFBI-treated animals when compared with normal
healthy ones. Administration of different plant extracts after
AFB1 injection improve to large extent these parameters levels
indicating the therapeutic role of these drugs.
This effect was pronounced in animals treated with green
tea (G3), galangal (G5) and frankincense (G7) where these
plants modulated most of these altered parameters nearly to
their normal levels. However, supplementation of AFB1 trea-
ted rats with MTX dramatically ampliﬁed the toxic effect of
AFB1 where the alterations in the studied parameters were
more pronounced in AFB1-MTX treated animals than
AFB1-treated ones.
The levels of some markers of energy metabolism in hearts
of rats of different experimental groups are shown in Table 2.
The result revealed marked decrease in glycogen and glucose
contents in the hearts of AFB1 administered animals accompa-
nied with a reduction in the glycolytic enzymes PGI, G3PDH
and LDH. Administration of the extracts of plants under
investigation, effectively up-regulate the decrease in these ener-
getic biomarkers. But MTX treatment severely aggravated
aﬂatoxicosis induced alteration in cardiac energy supply where
the deviation in the studied energetic indices were more evi-
dence in AFB1-MTX treated animals than AFB1-treated ones.
4. Discussion
This study was performed to evaluate the beneﬁcial therapeutic
ability of some traditional medicinal plant extracts against
mycotoxicosis induced in rat kidneys and hearts by aﬂatoxin
B1. Symptoms of mycotoxicosis are a result of interactions
of mycotoxins with functional molecules and subcellular
organelles in the animal cell.
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Therapeutic ability of some plant extracts on aﬂatoxin B1 induced renal and cardiac damage 5Results clearly indicate increase in MDA (index of lipid
peroxidation, LPO) in kidneys of aﬂatoxin-treated rats as
compared to control, suggesting kidney oxidative damage.
This is in agreement with ﬁndings reported previously for rat
liver (Abdel-Wahhab and Aly, 2003; El-Gibaly et al., 2003;
Liebert et al., 2006; Naaz et al., 2007). As well as liver and kid-
ney in mice (Verma and Nair, 1999; Choudhary and Verma,
2005).
Induction of LPO by AFB1 is considered one of the main
manifestations of oxidative damage initiated by reactive oxy-
gen species (ROS) and it has been linked with altered mem-
brane structure and enzyme inactivation. It is exhibited that
aﬂatoxin B1, with the help of microsomal cytochrome p-450
mediated oxidation, is biotransformed into aﬂatoxin 8-9-epox-
ide, which is a reactive intermediate and highly toxic (Niki
et al., 2005; Sharma and Farmer, 2004; Klein et al., 2002).
Cytochrome p-450 exhibits a key function in the biotrans-
formation of xenobiotics, catalyze the reductive transforma-
tion of foreign compounds and displays an oxidase activity
resulting in ROS formation (Towner et al., 2003; Sohn et al.,
2003). These species trigger cell damage through binding to cell
macromolecules as well as membrane, leading to membrane
peroxidation which affect the ionic permeability of the
membrane and eventually leading to the impairment of cell
functioning and cytolysis (Berg et al., 2004).
This is supported by previous investigation stated that
aﬂatoxin is a potent nephrotoxic compound leading to kidney
damage and changes in renal function. Also, previous histopa-
thological studies indicated that the exposure to aﬂatoxin B1
led to sever degenerative renal damage (Wangikar et al.,
2005; Dafalla et al., 1986; Gabal and Azzam, 1998; Tassari
et al., 2006).
Oxidative damage in the cell or tissue occurs when the con-
centration of ROS (superoxide radical, hydroxyl radical and
hydrogen peroxide) generated exceeds the antioxidant capabil-
ity of the cell (Sies and Stahl, 1995) or when the antioxidant
capacity of the cell decreases. Levels of non-enzymatic antiox-
idants (vitamin C) and enzymatic antioxidants (GR and G-6-
PDH) are the main determinants of the antioxidant defense
mechanism of the cell.
The signiﬁcant reduction in vitamin C level as well as in
activities of glutathione reductase (GR) and G-6-PDH (gluta-
thione metabolizing enzymes) in kidneys of AFB1 administered
rat could be responsible for increased lipid peroxidation ob-
served during aﬂatoxicosis. This result is agreed with previous
studies which revealed signiﬁcant reductions in enzymatic and
non-enzymatic antioxidants in AFB1-fed rat (El-Gibaly et al.,
2003; Choudhary and Verma, 2005).
Vitamin C, which includes ascorbic acid and its oxidation
product – dehydroascorbic acid, has many biological activities
in human body. It can be deﬁned as an enzyme cofactor, a rad-
ical scavenger, and as a donor/acceptor in electron transport at
the plasma membrane (Davey et al., 2000).
GR is the key enzyme in the conversion of oxidized glutathi-
one (GSSG) back to the reduced form (GSH). GSH scavenge
the electrophilic moieties produced by toxic chemicals and con-
jugate them to less toxic products (Anilakumar et al., 2004). It
also has an important role in the maintenance of vitamin C nor-
mal level. During free radical scavenging action, ascorbic acid is
transformed into L-dehydroascorbate (Breimer, 1990). GSH is
required for the conversion of L-dehydroascorbate back to
ascorbate (Preetha et al., 2006). The normal vitamin C level is
6 N. Ameen Abdulmajeeda therapeutic beneﬁt as it able to reduce oxidative stress
through reacting with superoxide radical and hydroxyl radicals
(Sies and Stahl, 1995).
So reduction in GR activity may lead to the fall in the level
of reduced glutathione and hence decreases the conversion of
L-dehydroascorbate to ascorbate and this probably explain
the lowered level of ascorbic acid in the aﬂatoxin-treated
animals. Glucose-6-phosphate dehydrogenase (G-6-PDH), a
rate-limiting enzyme of the pentose phosphate pathway, is re-
quired for NADPH generation which is needed for the mainte-
nance of GSH in its reduced form. Inhibition of G-6-PDH
activity may reduce the capacity of the tissue to protect itself
from the oxidative stress because less amount of NADPH is
produced (Zhang et al., 2000).
Supplementation of different plant extracts, potentially was
effective in reducing lipid peroxidation, and enhancing the
antioxidant status of kidney in AFB1-treated animals. It is
indicated by amelioration of MDA to near normal level and
signiﬁcant improvement the antioxidant defense system (GR,
G-6-PDH and vitamin C), suggesting their antioxidant poten-
tials. Two mechanisms can be postulated to the therapeutic ef-
fect of the used plant extracts against AFB1 renotoxicity. The
ﬁrst one is that these extracts may exert their beneﬁcial actions
through their direct antimicrobial activities. The second mech-
anism is based on their antioxidant abilities (proved from our
data), which may be responsible for protecting the cells against
the oxidative stress, possibly by increasing the endogenous
defensive capacity of the kidney to combat oxidative stress in-
duced by AFB1.
This emphasizes the fact that herbal medicines often contain
multiple active substances which have antimicrobial and anti-
oxidant activities. Some authors reported that several phenolic
compounds contribute to the overall antioxidant and antimi-
crobial activities of herbs against human pathogens The mech-
anisms of phenolic compounds for antioxidant activity are
mainly due to their redox properties and chemical structures,
which can act as reducing agents, free radical scavengers or
quenchers of the formation of singlet oxygen (Zheng and
Wang, 2001; Pizzaleet al., 2002; Puupponen-Pimia et al., 2005).
Green tea (G3) was found to posses antimicrobial activity. It
also contains polyphenols which have recently been reported
to be a potent antioxidant and beneﬁcial in oxidative stress,
and to inhibit the initiation of AFB1-induced carcinogenesis
in rats and mice. Epigallocatechin gallate, the main ingredient
of green tea extract, is a strong chemopreventing of toxic effects
of AFB1. It has an important role in converting AFB1 to
aﬂatoxicol which is less toxic, enhancing of glutathione-S-trans-
ferase (GST) activity and reducing the metabolic conversion
AFB1 to the AFB1-DNA adduct (Almajano et al., 2008; Panza
et al., 2008; Chen et al., 2004; Raza and John, 2005; Chou et al.,
2000; Ahmed et al., 2002; Tulayakul et al., 2007).
Caraway (G4) is rich in monoterpenes and is known for
its antimicrobial activity. In addition, previous studies show
that caraway contains potential antioxidant substances such
as the ﬂavonoids. Apart from antioxidant properties, caraway
also has an important role in reducing cytochrome P450
metabolic activity. Thus this may reduce the metabolic con-
version of AFB1 to the highly reactive intermediate, AFB1-
8,9-epoxide which has the major role in AFB1 toxicity
and carcinogenicity (Preston and Williams, 2005; Iacobellis
et al., 2005; Satyanarayana et al., 2004; Naderi-Kalali
et al., 2005).Galangal (G5) was found to have antimicrobial effect
which is related to the presence of several components acted
as antimicrobial agents. 1,8-Cineole, the main component of
galangal in the essential oil, has been previously reported to
have an antibacterial activity. It has a mechanism of action
against bacterial cells involving disruption of cytoplasmic
membrane and coagulation of cell contents. Also, several
researchers have reported that galangal showed antioxidant
activity in a model system (Viljoen et al., 2003; Oonmetta-aree
et al., 2006; Gachkar et al., 2007; Cheah and Abu-Hasim, 2000;
Javanmardi et al., 2003).
Frankincense (G6) oils was reported to exhibited antibacte-
rial and antifungal activities. The water-soluble fraction of the
frankincense show hepato-protective and reno-protective
property. It possess antioxidant activity as it has the ability
to inhibit induced nitric oxide (NO) and inﬂammatory media-
tors production under in vivo and in vitro condition (Umez,
2000; Pandey et al., 2005; Gayathri et al., 2007).
Cinchona (G7) (Cinchona ofﬁcinalis) was also exhibited
antimicrobial activity against bacteria and fungi which may re-
lated to the alkaloids (namely, quinine, quinidine, cinchonine
and cinchonidine) and steroids found in this plant (Rojas
et al., 2006).
Administration of the anticancer drug, MTX, to AFB1-
treated rats (G8) dramatically ampliﬁed the toxic effect of
AFB1 induced in kidney which was documented by elevated
MDA level with concomitant decrease in antioxidant defense
systems, vitamin C, GR and G-6-PDH compared with normal
animals. The behavior implicates the presence of oxidative tis-
sue damage. These deviations were more evidence in AFB1-
MTX treated animals than in AFB1-treated group.
This result is agreed with previous authors who reported
that administration of MTX induces lipid peroxidation accom-
panied by signiﬁcant reductions in antioxidant defense mecha-
nism in different tissues including kidney, which is considered
an important cause of destruction and damage to cell mem-
branes and has been suggested to be a contributing factor to
the development of MTX-mediated tissue damage (Cetiner
et al., 2005; Rajamani et al., 2006). The signiﬁcant reduction
in the glutathione metabolizing enzymes (GR and G-6-PDH)
as well as vitamin C induced by MTX may be explained by
previous studies demonstrated that the cytosolic NAD(P)-
dependent dehydrogenases are inhibited by MTX, suggesting
that the drug could decrease the availability of NADPH in
cells which is used by glutathione reductase to maintain the
cytosolic antioxidant glutathione in reduced state (Cetiner
et al., 2005; Caetano et al., 1997). Consequently, this may lead
to a reduction in the effectiveness of the antioxidant vitamin C
(Babiak et al., 1998).
Concerning with the effect of AFB1 administration on
some energy metabolism biomarkers in rat hearts, the results
revealed that marked decrease in glycogen and glucose con-
tents of animal hearts in response to aﬂatoxicosis accompanied
by a decrease in the glycolytic enzymes, Glyceraldehyde
3-phosphate dehydrogenase (GAPDH), glucose isomerase
(GI) and lactate dehydrogenase (LDH), suggesting that
AFB1 may interfere with the cellular energy supply through
its inhibitory action on glycogen synthesis, glucose uptake (a
decrease in glucose transport from blood to myocardial cells)
and glycolysis in heart. Similar result was obtained by Tessier
et al. (2003) who reported that cardiac glycolysis and glycogen
synthesis are impaired by a bacterial endotoxin in rats. Our
Therapeutic ability of some plant extracts on aﬂatoxin B1 induced renal and cardiac damage 7results are consisted with some authors who reported that
AFB1 decreases tissue glycogen by inhibiting the activities of
biosynthetic enzymes and stimulating glycogenolysis through
inhibiting intracellular cyclic adenosine monophosphate
(cAMP) hydrolysis, which responsible for phosphorylase acti-
vation, the rate-limiting enzyme for glycogen (Kiessling, 1986;
Bonsi et al., 1999).
Also it was found that AFB1 reduces glucose transport and
affects some enzymes engaged in glucose metabolism in the li-
ver. The reduction in glucose uptake may be attributed to the
decrease in the number of GLUT 1 and GLUT 4 transporters
in the sarcolemma in response to aﬂatoxicosis. These proteins
are normally stored in cytoplasmic membranes and can be re-
cruited to the plasma membrane as needed (Kiessling, 1986).
The loss of cardiac anaerobic glycolysis under the effect of
AFB1 toxicity may be ascribed to the low level of intracellular
glucose, in addition to the decrease in LDH activity may affect
the re-generation of NAD from NADH, the oxidizing equiva-
lents necessary to GAPDH, which sustains the continuous
operation of glycolysis and hence the rate of glycolysis will
be reduced (Brooks et al., 2003).
On the other hand, these enzymes may be released from
cardiac muscle ﬁbers due to aﬂatoxicosis causing tissue dam-
age. The later suggestion is conﬁrmed by histopathological
investigations proved that gross cardiac anomalies due to
AFB1 indicated by dilation of the heart and fusion of auricu-
lo-ventricular valve leading to obstruction of passage of the
blood from auricles to ventricles, vaculations and degeneration
of cardiac muscle ﬁbers (Liebert et al., 2006).
Glycogen utilization through glycolysis is one of the meta-
bolic pathways which directly participate in generation of suf-
ﬁcient adenosine triphosphate (ATP) to meet energy demands
of the heart. The myocyte requires continuos production of
ATP to survive because it cannot be stored. Alterations of such
bioenergetic sources which have a crucial role in cellular pro-
tection may render the heart susceptible to metabolic stress
and affect the myocardial contractile performance, leading
heart failure. This is supported by some authors who reported
that exposure to aﬂatoxin B1 toxicity caused heart defects
(Carvajal and Sa´nchez, 2003; Mancini et al., 1999; Pasha
et al., 2007).
Administration of different plant extracts, effectively mod-
ulate the lowered levels of glycogen and glucose as well as the
activities of the key enzymes involved in glucose metabolism in
hearts of rats in response to aﬂatoxicosis. Modulation of the
heart energy metabolism by the used drugs could be beneﬁcial
to the amelioration of events leading to cardiopathy. No com-
parable data are so far available for the effect of these plants
on the heart energy metabolism, however, the possible mecha-
nisms which may explain this good effect of the tested different
plant extracts are that they may have a crucial role in inducing
the enzymes implicated in glycogen synthesis and have the abil-
ity to increase glucose uptake by modulating the alterations in
the glucose transporter GLUT in the cardiac muscle affected
by AFB1. Also, the amelioration of glycolytic enzyme activi-
ties may attributed to the availability of glucose, in addition
these extracts may have a direct beneﬁcial action in cardiac tis-
sue repair due to their antioxidant abilities as previously men-
tioned, thus preventing enzymes release.
Administration of MTX to AFB1-treated animals aggra-
vates the cardiotoxic effect of AFB1 via decreasing the energy
metabolic markers in the animal hearts which was ensured bythe reduction in the glucose and glycogen contents of the heart
with concomitant decrease in the tested glycolytic enzymes.
These alterations were more severe in AFB1-MTX treated rats
than in AFB1-treated group. The decrease in the glucose by
MTX may ascribed to its ability to decrease glucose transport
into the cells as one of its mechanism of actions against tumor
cells. This ﬁnding is supported by previous authors who de-
clared that MTX inhibited glucose uptake by Ehrlich ascites
cells (Fung et al., 1986). The decrease in glycogen may attrib-
uted to either the inhibitory action of MTX on glycogen syn-
thesis or the reduction of intracellular cardiac glucose, the
substrate for glycogen synthesis. The decrease in glycolytic en-
zymes may be resulted from either the decrease in cardiocyte
glucose content or the release of these enzymes due to tissue
damage. This is ensured by some authors reported that treat-
ment of rat hepatocyte with MTX for 24 h resulted in increase
in enzyme leakage supporting the conclusion that MTX was
cytotoxic agent in rat hepatocyte (Walker et al., 2000). Our
data collectively support the hypothesis that cellular oxidative
stress is unpredictable side effects of MTX and may consider a
critical step in MTX-mediated injury (Sener et al., 2006).
In conclusion, our results have shown that all aqueous ex-
tracts of the examined plants alleviate AFB1 induced kidney
oxidative stress and alteration of cardiac energy metabolism
and can be regarded as good therapeutic agents against
aﬂatoxicosis.
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